Schonfeld Strategic Advisors’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-163,058
| Closed | -$417K | – | 2274 |
|
|
2025
Q1 | $417K | Buy |
+163,058
| New | +$417K | ﹤0.01% | 1535 |
|
|
2024
Q3 | – | Sell |
-27,900
| Closed | -$32.6K | – | 2157 |
|
|
2024
Q2 | $32.6K | Buy |
+27,900
| New | +$32.6K | ﹤0.01% | 1836 |
|
|
2021
Q2 | – | Sell |
-89,278
| Closed | -$399K | – | 2164 |
|
|
2021
Q1 | $399K | Buy |
+89,278
| New | +$399K | ﹤0.01% | 1182 |
|